The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Open accessAbstract
Depression is the most prevalent and among the most debilitating of psychiatric disorders. The precise neurobiology of this illness is unknown. Several lines of evidence suggest that peripheral and central inflammation plays a role in depressive symptoms, and that anti-inflammatory drugs can improve depressive symptoms in patients with inflammation-related depression. Signaling via brain-derived neurotrophic factor (BDNF) and its receptor, tropomycin receptor kinase B (TrkB) plays a key role in the pathophysiology of depression and in the therapeutic mechanisms of antidepressants. A recent paper showed that lipopolysaccharide (LPS)-induced inflammation gave rise to depression-like phenotype by altering BDNF-TrkB signaling in the prefrontal cortex, hippocampus, and nucleus accumbens, areas thought to be involved in the antidepressant effects of TrkB agonist, 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist, ANA-12. Here we provide an overview of the tryptophan-kynurenine pathway and BDNF-TrkB signaling in the pathophysiology of inflammation-induced depression, and propose mechanistic actions for potential therapeutic agents. Additionally, the authors discuss the putative role of TrkB agonists and antagonists as novel therapeutic drugs for inflammation-related depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. (1) The relationship between sickness behavior and depression-like behavior. (A): The sickness behavior that peaks 2 to 6 hours later and gradually wanes by peripheral administration of lipopolysaccharide (LPS). Pro-inflammatory cytokine signaling is activated in the brain as a response to peripheral LPS injection, with depression-like behavior peaking 24 hours after LPS injection. (B): The sickness behavior was induced by pro-inflammatory cytokines which also can enhance activity of the ubiquitous indoleamine 2,3-dioxygenase (IDO), peaking 24 hours after LPS administration. Activation of IDO results in decreased tryptophan (TRP) levels and increased production of kynurenine (KYN) and other tryptophan-derived metabolites. Anti-inflammatory drugs (e.g. minocycline) can block both LPS-induced sickness behavior and depression-like behavior. By contrast, administration of 1-methyl tryptophan (1-MT), a competitive inhibitor of IDO, blocks LPS induced depression-like behavior without altering LPS-induced sickness behavior. This figure is a modified version from a previous report [45].](https://figures.cochat.ai/paper-figures/02a8055227f149d3acdd0bcacaaab723/brain-derived-neurotrophic-factor-bdnf-trkb-signaling-in-inflammation-related-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the treatment of depression, targeting signaling transduction by BDNF and its receptor, tropomycin receptor kinase B (TrkB), is essential. 143 , 144”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [144]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu121 · Cited by 103 · cited 2×
“In the rat learned helplessness model, we found that BDNF levels in the NAc were significantly higher in depressed rats compared with control and resilient rats, suggesting again that regional differences in BDNF levels may promote resilience to inescapable stress [113].”
Self-citationRetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 7×
“IDO activation results in decreased tryptophan levels and increased production of kynurenine and other tryptophanderived metabolites [36, 45].”
InfluentialA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Metaanalysis showed higher serum levels of TNF-α in drug-free depressed patients relative to healthy controls [26].”
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404 · cited 1×
“Administration of LPS or pro-inflammatory cytokines results in a significant reduction of BDNF gene and protein expression [38, 92].”
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 2×
“It is well known that BDNF is integral to use-dependent plasticity mechanisms, such as long-term potentiation, learning and memory [80-85].”
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Research works printed but not linked: 2
- [97]Duman R.S. Heninger G.R. Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997 54 7 597 606 [http://dx.doi.org/10.1001/archpsyc.1997.01830190015002]. [PMID: 9236543]. 9236543 · DOI · Paper page
- [102]Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog. Neurobiol. 2013 100 15 29 [pneurobio.].[http://dx.doi.org/10.1016/j.pneurobio.2012.09.001]. [PMID: 23044468]. 23044468 · DOI · Paper page
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335
Self-citationDiet and Mental Health: Review of the Recent Updates on Molecular Mechanisms
Godos, J., Currenti, W., Angelino, D., Mena, P., Castellano, S., Caraci, F., Galvano, F., Del Rio, D., Ferri, R., & Grosso, G. (2020) · Antioxidants · doi:10.3390/antiox9040346 · Cited by 258
“Cytokines are soluble intercellular signaling molecules that are involved in the pathophysiology of several mental disorders through affecting neurotransmitter synthesis, release, and reuptake [79], as well as regulating BDNF expression [80].”
BackgroundMolecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01121-1 · Cited by 248
Self-citationMolecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Hashimoto, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113935 · Cited by 236
Self-citation
Metadata
- Authors
- Zhang, J.-C., Yao, W., & Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-08-26
- Volume
- 14
- Issue
- 7
- Pages
- 721-731
- ISSN
- 1570-159X (ISSN-L)
- PMC
- PMC5050398
- OpenAlex
- W2309165118
- Cited by
- 538
- References
- 131
- Citations by year
- 2026: 46 · 2025: 71 · 2024: 70 · 2023: 71 · 2022: 65 · 2021: 60 · 2020: 64 · 2019: 37 · 2018: 22 · 2017: 18 · 2016: 14
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Current Neuropharmacology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (24116006)
- Japan Society for the Promotion of Science (15K19711)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, TrkB signaling, neuroinflammation, kynurenine pathway, lipopolysaccharide-induced inflammation, antidepressant mechanism, 7,8-dihydroxyflavone, ANA-12, TrkB agonist, prefrontal cortex, hippocampus, nucleus accumbens
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antidepressive Agents, Brain, Depressive Disorder, Humans, Inflammation, Brain-Derived Neurotrophic Factor, Receptor, trkB
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets. https://app.cochat.ai/papers/10.2174/1570159x14666160119094646
- The paper
- Zhang, J.-C., Yao, W., & Hashimoto, K. (2016). Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets. Current Neuropharmacology. https://doi.org/10.2174/1570159x14666160119094646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.